AU2002359347A1 - Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) - Google Patents

Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)

Info

Publication number
AU2002359347A1
AU2002359347A1 AU2002359347A AU2002359347A AU2002359347A1 AU 2002359347 A1 AU2002359347 A1 AU 2002359347A1 AU 2002359347 A AU2002359347 A AU 2002359347A AU 2002359347 A AU2002359347 A AU 2002359347A AU 2002359347 A1 AU2002359347 A1 AU 2002359347A1
Authority
AU
Australia
Prior art keywords
tace
tnf
inhibitors
beta
converting enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359347A
Inventor
Jingwu Duan
Gregory Ott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2002359347A1 publication Critical patent/AU2002359347A1/en
Abandoned legal-status Critical Current

Links

AU2002359347A 2001-11-02 2002-11-01 Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) Abandoned AU2002359347A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/335,962 2001-11-02

Publications (1)

Publication Number Publication Date
AU2002359347A1 true AU2002359347A1 (en) 2003-05-19

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003282920A1 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
AU2002357312A1 (en) Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
AU2003220401A1 (en) Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
AU2002341715A1 (en) Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
AU4180900A (en) Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase
AU2003261319A1 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
AU2003261434A1 (en) Iminothiazolidinones as inhibitors of hcv replication
AU2002238418A1 (en) Use of DNA repair enzymes as MMP-1 inhibitors
AU2002324716A1 (en) Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
AU4181000A (en) Novel lactam inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase
AU2002365132A1 (en) BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-Alpha CONVERTING ENZYME (TACE)
AU2003301903A1 (en) Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU2002346729A1 (en) Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
AU2003237983A1 (en) Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors
AU2003217916A1 (en) Stable formulations of angiotensin converting enzyme (ace) inhibitors
AU2002246983A1 (en) 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
AU3719100A (en) Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003290417A1 (en) Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
AU2001274344A1 (en) Tissue inhibitors of matrix metalloproteinases
AU2002258507A1 (en) Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
AU2002359347A1 (en) Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
AU2002236120A1 (en) Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
AU2003228701A1 (en) Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases